Related Experiment Video
Updated: Jun 20, 2026

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency
Published on: February 2, 2024
Targeting Notch signaling in pancreatic cancer patients--rationale for new therapy
1Service de Gastroentérologie (Labo), Département de Médecine, Faculté de Médecine et des Sciences de la Santé (CHUS -Fleurimont), Université de Sherbrooke, Sherbrooke, Canada.
Abstract:
Pancreatic cancer is one of the most aggressive and devastating human malignancies. Despite new knowledge in the molecular profile of pancreatic cancer and its precursor lesions, survival rates have changed very little over the last 40 years. Therefore, a better understanding of the detailed mechanisms underlying the pathogenesis of this disease is critical if we expect to develop new and effective strategies for prevention, early diagnosis and treatment of pancreatic cancer. The review herein focuses on a distinctive signaling pathway, the Notch pathway, which has recently been associated with carcinogenesis, including pancreatic cancer. It is aimed at summarizing key results which support a role for this pathway in the initiation, progression and maintenance of pancreatic cancer as a rationale for targeting and inhibiting this pathway in pancreatic cancer patients.
Insights
Pancreatic cancer remains deadly, with little survival improvement. This review explores the Notch pathway
Area of Science:
- Oncology
- Molecular Biology
- Cell Signaling
Background:
- Pancreatic cancer has dismal survival rates despite advances in molecular understanding.
- Effective prevention, early diagnosis, and treatment strategies require deeper insight into disease mechanisms.
Purpose of the Study:
- To review the role of the Notch signaling pathway in pancreatic cancer.
- To provide a rationale for targeting the Notch pathway in pancreatic cancer therapy.
Main Methods:
- Literature review of studies investigating the Notch pathway in pancreatic cancer.
- Analysis of molecular and cellular mechanisms linking Notch signaling to pancreatic cancer pathogenesis.
Main Results:
- The Notch pathway is implicated in the initiation and progression of pancreatic cancer.
- Evidence suggests Notch signaling is crucial for maintaining pancreatic tumors.
Conclusions:
- The Notch pathway is a promising therapeutic target for pancreatic cancer.
- Inhibiting the Notch pathway may offer new treatment strategies for patients.
Related Concept Videos
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...

